Examkin

Question

Difficulty: MediumPreventive Care and Immunizations

A 15-month-old boy is brought to the clinic for a routine well-child visit. He has not received any immunizations since his 6-month well-child visit due to missed appointments. Five months ago, he was hospitalized for 5 days and successfully treated with high-dose intravenous immunoglobulin (IVIG) and aspirin for Kawasaki disease. He currently takes no medications and has no other medical conditions. His parents express concern because he is not yet running or speaking in two-word phrases. He currently walks independently, drinks from a cup, and says three specific words other than "mama" and "dada". Vital signs are within normal limits, and physical examination shows no abnormalities. Which of the following is the most appropriate next step in the management of this patient?

  1. Reassure the parents regarding development, administer indicated inactivated vaccines, and defer live-attenuated vaccines.Answer
  2. B
    Reassure the parents regarding development and administer all indicated vaccines, including live-attenuated vaccines.
  3. C
    Refer for a developmental evaluation, administer indicated inactivated vaccines, and defer live-attenuated vaccines.
  4. D
    Refer for a developmental evaluation and administer all indicated vaccines, including live-attenuated vaccines.
  5. E
    Reassure the parents regarding development and defer all immunizations until 11 months have elapsed since hospitalization.

Answer

Reassure the parents regarding development, administer indicated inactivated vaccines, and defer live-attenuated vaccines.
The correct approach is to reassure the parents about their child's development and administer only inactivated vaccines while deferring live-attenuated vaccines. At 15 months of age, walking independently and speaking 3 to 5 words is developmentally normal. The skills the parents are concerned about—running and speaking in two-word phrases—are milestones that are typically achieved by 24 months of age, so a developmental referral is not indicated. Furthermore, this patient requires catch-up immunizations. Because he received high-dose IVIG for Kawasaki disease 5 months ago, passively acquired antibodies are still present in his circulation. These antibodies can neutralize live-attenuated viruses (such as the measles, mumps, rubella, and varicella vaccines), rendering the vaccines ineffective. Therefore, live-attenuated vaccines must be deferred for a total of 11 months following high-dose IVIG therapy. In contrast, IVIG does not interfere with the immune response to inactivated vaccines (such as DTaP, Hib, PCV, HepA, and IPV), which should be administered immediately to provide timely protection.

Step-by-Step Solution

1
Evaluate the child's developmental milestones based on parental concerns.
The child walks independently, drinks from a cup, and speaks 3-5 words, which aligns with normal 15-month milestones. Running and two-word phrases are 24-month milestones.
To determine if the parental concern warrants a referral for developmental delay or simple reassurance.
2
Assess the appropriate immunization schedule in the context of recent high-dose IVIG therapy.
Inactivated vaccines can be safely administered, but live-attenuated vaccines must be deferred.
High-dose IVIG contains circulating antibodies that can neutralize live vaccine viruses (such as MMR and Varicella) for up to 11 months, rendering them ineffective. IVIG does not impact the efficacy of inactivated vaccines.

Key Concept

High-dose IVIG therapy requires delaying the administration of live-attenuated vaccines for up to 11 months due to antibody interference, whereas inactivated vaccines can be given on their normal schedule. Running and speaking in two-word phrases are normal 24-month milestones, not expected at 15 months.
Estimated Time:1m 0s
Rate this question

Topics

Preventive Care and Immunizations

More questions from this topic